A prospective and real-world study on the application of fully automated CT derived fractional flow reserve

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053219

Enrollment

Unknown

Registered

2021-11-16

Start date

2021-05-01

Completion date

Unknown

Last updated

2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

experimental group vs. control group:CCTA guided clinical decisions vs. CCTA+CT-FFR guided clinical decisions

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged > 18 years; 2. Providing written informed consent; 3. Coronary artery CTA examination can be performed, and the degree of the coronary stenosis is more than 25%.

Exclusion criteria

Exclusion criteria: 1. Patients with the acute coronary syndrome; 2. Patients underwent coronary revascularization (stent placement or coronary artery bypass graft surgery) 3. Complex congenital heart disease other than anomalous coronary origins alone; 4. Any active, serious, life-threatening disease; 5. Inability to comply with study follow-up requirements.

Design outcomes

Primary

Measure	Time frame
Rate of invasive coronary angiography within 90 days;	—

Secondary

Measure	Time frame
Major Adverse Coronary Event;	—

Countries

China

Contacts

Public ContactLongjiang Zhang

General Hospital of Eastern Theater Command

kevinzhlj@163.com+86 13405833176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026